Jiangsu Hengrui Pharmaceuticals announced that its subsidiary Shanghai Hengrui Pharmaceuticals and Shanghai Shengdikai Pharmaceuticals received the clinical trial approval notice issued by the National Medical Products Administration for the injectable SHR-1501 and Abediterol monoclonal antibody injection, and will soon conduct clinical trials for non-muscle invasive bladder cancer.
- Latest
- Detail
恒瑞医药：阿得贝利单抗注射液临床试验获批
Jiangsu Hengrui Pharmaceuticals: The clinical trial for Abediterol monoclonal antibody injection has been approved.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
19:23
Xiaohongshu (Little Red Book) has officially released a complete grass planting measurement solution.
JD+1.53%
19:20
Russia claims that the Ukrainian army's advance in Kursk Oblast has been halted while Ukraine announces continued operations.
19:19
Qinghai Salt Lake Industry: The shareholding ratio of the National Development Bank has fallen below 5%.
Qinghai Salt Lake Industry+0.42%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.